imaging biomarker

World Multiple Sclerosis Day, as a day of global solidarity, emphasizes the need to raise awareness of this disease, improve diagnosis and treatment, and fund research to curb multiple sclerosis.

At mediri we develop and refine structural analysis methods to support the diagnosis and follow-up of multiple sclerosis.
An important imaging biomarker for MS is smouldering lesions. Their AI-aided detection on MR images also makes disease activity visible that cannot be seen with the naked eye.

We see a rapidly increasing need for medical imaging in clinical trials and in the development of standardized imaging biomarkers. In 2022, more than 1900 clinical trials were registered in Germany. In many of them, medical imaging is used in as a primary, quantitative and surrogate biomarker.

New AI developments across the healthcare industry, with radiology at the forefront, continue to increase the need for medical imaging core lab services.
As an Imaging CRO and Core Lab, we make your image-based clinical trials more efficient, faster and safer. This is especially important when it comes to multi-center studies that place high demands on comparability of image data.

Contact us to discuss our medical imaging solutions for reliable clinical trial results.

Working visit at Amsterdam UMC: The partners in the ASPIRE project spent two days at Amsterdam UMC to pave the way for the final year. ASPIRE will ease the access to non-invasiv imaging biomarkers in dementia and help to get ASL into the clinics.